Literature DB >> 16647772

Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism.

Michael P Caligiuri1, Hans-Leo Teulings, J Vincent Filoteo, David Song, James B Lohr.   

Abstract

Monitoring drug-induced side effects is especially important for patients who undergo treatment with antipsychotic medications, as these drugs often produce extrapyramidal side effects (EPS) resulting in movement abnormalities similar to parkinsonism. Scientists have developed several objective laboratory tests to measure and research drug-induced movement disorders, but equipment and tests are complex and costly and have not become accepted in large-scale, multi-site clinical trials. The goals of this study were to test whether a simple handwriting measure can discriminate between individuals with psychotropic-induced parkinsonism, Parkinson's disease, and healthy individuals, and to examine some of the psychometric properties of the measure. We examined pen movement kinematics during cursive writing of a standard word in 13 patients with idiopathic Parkinson's disease (PD), 10 schizophrenia patients with drug-induced parkinsonism (SZ), and 12 normal healthy control participants (NC). Participants were instructed to write the word "hello" in cursive twice, at three vertical height scales. Software was used for data acquisition and analysis of vertical stroke velocities, velocity scaling, and smoothness. There were four important results from this study: (1) both SZ patients with drug-induced EPS and PD participants exhibited impaired movement velocities and velocity scaling; (2) performance on the velocity scaling measure distinguished drug-induced EPS from normal with 90% accuracy; (3) SZ, but not PD participants displayed abnormalities in movement smoothness; and (4) there was a positive correlation between age and magnitude of the velocity scaling deficit in PD participants. This study demonstrates that kinematic analyses of pen movements during handwriting may be useful in detecting and monitoring subtle changes in motor control related to the adverse effects of psychotropic medications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647772     DOI: 10.1016/j.humov.2006.02.004

Source DB:  PubMed          Journal:  Hum Mov Sci        ISSN: 0167-9457            Impact factor:   2.161


  18 in total

1.  Validation studies of the human movement analysis panel for hand/arm performance.

Authors:  Charles D Smith; Ashley Walton; John T Slevin; Greg A Gerhardt; Gloria Umberger; Kyle Smoot; Emily Schulze; Don Gash
Journal:  J Neurosci Methods       Date:  2007-06-22       Impact factor: 2.390

2.  Hallucinations and tremors due to oral therapeutic doses of erythromycin and methylprednisolone.

Authors:  Massimo Gallerani; Benedetta Boari
Journal:  Intern Emerg Med       Date:  2008-02-13       Impact factor: 3.397

3.  The nature of bradykinesia in schizophrenia treated with antipsychotics.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; James B Lohr
Journal:  Psychiatry Res       Date:  2019-01-15       Impact factor: 3.222

4.  Longitudinal Assessment and Functional Neuroimaging of Movement Variability Reveal Novel Insights Into Motor Dysfunction in Clinical High Risk for Psychosis.

Authors:  Derek J Dean; Jessica A Bernard; Katherine S F Damme; Randall O'Reilly; Joseph M Orr; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

5.  Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James B Lohr
Journal:  Psychiatry Res       Date:  2010-04-09       Impact factor: 3.222

6.  Motion energy analysis reveals altered body movement in youth at risk for psychosis.

Authors:  Derek J Dean; Alayna T Samson; Raeana Newberry; Vijay A Mittal
Journal:  Schizophr Res       Date:  2017-06-03       Impact factor: 4.939

7.  Motor behavior reflects reduced hemispheric asymmetry in the psychosis risk period.

Authors:  Derek J Dean; Joseph M Orr; Raeana E Newberry; Vijay A Mittal
Journal:  Schizophr Res       Date:  2015-10-20       Impact factor: 4.939

8.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

9.  Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James Lohr
Journal:  Hum Mov Sci       Date:  2009-08-18       Impact factor: 2.161

10.  [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 3 : Tardive dyskinesia].

Authors:  D Hirjak; K M Kubera; S Bienentreu; P A Thomann; R C Wolf
Journal:  Nervenarzt       Date:  2019-05       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.